期刊文献+

中医药治疗肺间质纤维化进展 被引量:2

下载PDF
导出
摘要 肺间质纤维化是对各种原因引起的肺泡损害的一种应答反应。中医药治疗肺间质纤维化已成为医学相关领域研究的热点。本文参阅近年来相关文献,就肺间质纤维化的发病机制和中医药防治的研究状况进行概述。
出处 《中医药通报》 2015年第1期69-71,共3页 Traditional Chinese Medicine Journal
基金 国医大师洪广祥全国名老中医药专家传承工作室 国家自然科学基金(No.81260537) 国家自然科学基金(No.81460708) 江西省高等学校科技落地计划项目(No.KJLD13063) 江西省自然科学基金(No.20132BAB205093)
  • 相关文献

参考文献32

二级参考文献168

共引文献368

同被引文献51

  • 1蔡后荣.间质性肺疾病的临床治疗进展[J].临床内科杂志,2005,22(4):223-226. 被引量:11
  • 2董彦,魏路清.间质性肺疾病治疗现状[J].临床荟萃,2005,20(8):474-475. 被引量:2
  • 3杨超,夏永良,宋康.从痰从瘀论治肺纤维化[J].中医药学刊,2006,24(6):1061-1062. 被引量:28
  • 4黄玉芳,马承立,刘书盈.特发性肺纤维化的发病机制及抗凝治疗研究进展[J].山东医药,2006,46(34):77-78. 被引量:2
  • 5American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board ofdirectors,June 2001 and by the ERS Executive Committee, June 2001[J]. Am J Respir Crit Care Meal,2002,165(2) :277- 304.
  • 6Murray LA,Chen Q,Kramer MS,et al. TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P[J]. Int J Biochem Cell Biol,2011,43(1) : 154-162.
  • 7Raghu G,Collard HR, Egan J J, et al. An official ATS/ERS/ JRS/ALAT statement: idiopathic pulmonary fibrosis evidence-based guidelines for diagnosis and management[J]. Am J Respir Crit Care Med,2011,183(6) :788-824.
  • 8Fiorucci E, Lucantoni G, Paone G, et al. Colchicine, cyclophosphamide and prednisone in the treatment of mild- moderate idiopathic pulmonary fibrosis: comparison of three currently available therapeutic regimens[J]. Eur Rev Med Pharmacol Sci, 2008,12 (2) : 105-111.
  • 9Shimbori C,Shiota N, Okunishi H. Effects of montelukast, a cysteinyl-leukotriene type I receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice [J]. Eur J Pharmacol,2011,650(1) :424-430.
  • 10King TE J r, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis[J]. N Engl J Med,2014,370(22):2083-2092.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部